Showing results (471-480 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|March 1, 1984
Malignant peripheral nerve tumors: a clinicopathological and electron microscopic studyO Arpornchayanon, T Hirota, M Itabashi, et al.
Japanese Journal of Clinical Oncology|September 5, 2022
Association between tumor response to systemic therapy and patient-reported disease symptomsYu Ito, Nobuyasu Awano, Naoko Takahashi, et al.
Japanese Journal of Clinical Oncology|March 21, 2002
A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancerK Hotta, I Sekine, T Tamura, et al.
Japanese Journal of Clinical Oncology|October 1, 1993
A ureteral small cell carcinoma mixed with malignant mesodermal and ectodermal elements: a clinicopathological, morphological and immunohistochemical studyM Tsutsumi, M Kamiya, M Sakamoto, et al.
Japanese Journal of Clinical Oncology|February 9, 2021
The role of radiotherapy in the age of immunotherapyHiro Sato, Sandra Demaria, Tatsuya Ohno
Japanese Journal of Clinical Oncology|February 17, 2021
Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study)Yoshihiko Tomita, Go Kimura, Satoshi Fukasawa, et al.
Japanese Journal of Clinical Oncology|February 21, 2021
The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancerTsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, et al.
Japanese Journal of Clinical Oncology|February 23, 2021
Prognostic impact of prior local therapy in castration-resistant prostate cancerMikifumi Koura, Masaki Shiota, Shohei Ueda, et al.
Japanese Journal of Clinical Oncology|February 26, 2021
Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patientsShicong Lai, Xingbo Long, Pengjie Wu, et al.
Japanese Journal of Clinical Oncology|October 1, 2019
Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policyTomonori Mizutani, Kenichi Nakamura, Haruhiko Fukuda, et al.
Pageof 534